Life sciences and diagnostics company Revvity has had a busy couple of years, playing a major role in the next-generation sequencing-based screening of newborns to better enable healthcare ...
Watchmaker Genomics, an innovator in high-performance solutions for next-generation sequencing (NGS), today announced a non-exclusive license with Caribou Biosciences, Inc., a leading clinical-stage ...
News-Medical.Net on MSN
Next-generation sequencing expands possibilities for newborn screening
Every year, millions of newborns undergo routine screening as a preventive strategy to detect inherited disorders before ...
Routine newborn screening (NBS) has transformed early disease detection. However, traditional biochemical tests limit the ...
A review explores how next-generation sequencing may expand newborn screening and highlights key clinical and ethical challenges.
As next-generation sequencing (NGS) applications expand, researchers face growing pressure to generate accurate, uniform data from increasingly complex and low input samples.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results